Elicio Therapeutics, Inc.

General ticker "ELTX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $136.7M (TTM average)

Elicio Therapeutics, Inc. follows the US Stock Market performance with the rate: 38.6%.

Estimated limits based on current volatility of 4.4%: low 9.96$, high 10.87$

Factors to consider:

  • Earnings expected soon, date: 2026-05-12 bmo
  • Total employees count: 32 as of 2024
  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [4.74$, 12.32$]
  • 2026-12-31 to 2027-12-31 estimated range: [3.73$, 10.12$]

Financial Metrics affecting the ELTX estimates:

  • Negative: with PPE of -3.1 at the end of fiscal year the price was high
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -30.15 <= 0.07
  • Positive: Investing cash flow per share per price, % of -0.01 > -0.65
  • Negative: Shareholder equity ratio, % of 6.33 <= 19.49
  • Negative: negative Net income
  • Positive: Interest expense per share per price, % of 0.92 <= 3.29
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: negative Industry operating cash flow (median)

Similar symbols

Short-term ELTX quotes

Long-term ELTX plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $35.74MM $44.99MM $37.71MM
Operating Income $-35.74MM $-44.99MM $-37.71MM
Non-Operating Income $0.55MM $-6.91MM $-1.86MM
Interest Expense $1.06MM $0.46MM $1.13MM
R&D Expense $22.68MM $33.66MM $24.90MM
Income(Loss) $-35.20MM $-51.90MM $-39.57MM
Profit(Loss)* $-35.20MM $-51.90MM $-39.57MM
Stockholders Equity $11.37MM $-11.31MM $1.64MM
Assets $27.15MM $28.18MM $25.86MM
Operating Cash Flow $-32.69MM $-37.07MM $-36.95MM
Capital expenditure $0.07MM $0.09MM $0.02MM
Investing Cash Flow $-0.03MM $-0.08MM $-0.02MM
Financing Cash Flow $38.61MM $42.32MM $36.70MM
Earnings Per Share** $-6.96 $-4.25 $-2.58

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.